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Abstract 
Kelly Liu: Influenza Viral Infection—Can Fatty Acids Change Infectivity? 
 
The 2009 H1N1 pandemic identified obesity as a risk factor not only for complications and 
death related to influenza but also as a risk factor for infection despite vaccination.7, 10, 11 The 
virus replicates by budding from the host cell membrane, and this project aims to determine 
if the differential fatty acid composition of obese individuals’ serum may be responsible for 
the increased infectivity.8 Lung epithelial cells (A549) were grown in palmitate (16:0), oleic 
acid (18:1), or linoleic acid (18:2) at different concentrations, exposed to 128 HAU influenza 
virus, and the amount of infectious virus produced in each condition was determined by the 
TCID50 assay protocol. At 2 hours post-infection, the viral titer of cells incubated in 50 !" 
polyunsaturated fatty acid (PUFA), 1.47×10! TCID50, was significantly greater than that of 
cells incubated in 200 !" PUFA, 2.37×10! TCID50, 50 !" monounsaturated fatty acid 
(MUFA), 1.38×10! TCID50, and 50 !" saturated fatty acid (SFA), 1.33×10! TCID50. At 5 
hours post-infection, the TCID50 from cells incubated in 50 !" PUFA, 1.00×10! TCID50, 
was significantly greater than that of cells incubated in 50 !" MUFA, 2.85×10! TCID50, 
and control vehicle, 1.00×10! TCID50. Cells incubated in 50 !" PUFA also produced a 
significantly greater average TCID50, 7.4985×10! TCID50, than all other conditions. 
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Introduction 
 Influenza is a seasonal virus that causes annual epidemics, resulting in 3 to 5 million 
cases of illness and 290,000 to 650,000 influenza related deaths yearly.7 The influenza 
viruses A and B are typically the types that cause seasonal epidemics in humans.6 Various 
factors increase one’s risk of influenza related complications including age and chronic 
medical conditions; however, the 2009 H1N1 pandemic of influenza A brought a new risk 
factor to light: obesity.7, 10 Obesity is defined as an adult having a Body Mass Index 
(BMI= !"#$!! !" !"!!"#!! !" ! !) equal to or greater than 30 or a child having a BMI equal to or greater 
than the 85th percentile for their age and height.13 This is of particular concern in the United 
States, as data from the 2013-2014 National Health and Nutritional Examination Surveys 
indicates that 37.7% of adults are obese and 16.7% of children and adolescents aged 2 to 19 
years old are obese. In addition, 32.5% of U.S. adults are overweight and considered to be at 
an increased risk of obesity.13 National trends of increasing obesity are concerning with its 
newfound role in influenza infection and complication. There is a higher risk of influenza-
related hospitalization for those who have a BMI equal to or greater than 30 and an increased 
odds of death correlating with a BMI equal to or greater than 40.10 In addition to increasing 
risk of influenza-related complications and death, obesity similarly increases risk of influenza 
infection, even if the individual is vaccinated. In comparison to healthy weight counterparts, 
vaccinated obese individuals have twice the risk of contracting the flu.11 The exact role of 
obesity in increasing risk of influenza infection and complication has yet to be determined. 
 The influenza virus is an enveloped virus with a lipid bilayer containing 
hemagglutinin, neuraminidase, and matrix 2 protein.18 The subtype of illness is based on the 
subtype of the hemagglutinin and neuraminidase proteins. For example, the swine flu 
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pandemic influenza strain was H1N1, as it had subtypes hemagglutinin 1 and neuraminidase 
1.6 The virus infects the host cell and replicates via budding off the plasma membrane of the 
infected host.8 Infection begins as hemagglutinin on the lipid bilayer of the virus binds to a 
sialic acid residue on the host cell, and the virus enters the host via receptor-mediated 
endocytosis. With endocytosis, the virus is in an endosome that has a pH of 5 to 6, which 
triggers fusion of the viral and endosomal membranes. Following transcription and 
replication of the viral genome, viral particles bud from the apical side of the host cell 
membrane.18 It is hypothesized that the aggregation of hemagglutinin and neuraminidase in 
lipid rafts of the host cell membrane causes a change in the curvature of the membrane, thus 
initiating viral budding.17  
It has been determined that the influenza viral envelope contains a higher ratio of 
saturated fatty acids to unsaturated fatty acids in comparison to the host cell.8, 17 A previous 
study by Kohn et al. examined the effects of incubating various viruses, including Influenza 
A, with various fatty acids, such as linoleic acid (18:2), oleic acid (18:1), and stearic acid 
(18:0).8 Fatty acids are capable of a wide array of direct effects on a cell as well as creating 
downstream effects. Incorporation of fatty acids into a cellular membrane changes the 
membrane fluidity and permeability.5 While unsaturated fatty acids increase membrane 
fluidity by being unable to pack close together due to kinks introduced by double bonds, 
saturated fatty acids lack a double bond and are able to pack close together, increasing 
membrane rigidity.21 The study concluded that the incubation with unsaturated fatty acids led 
to loss of viral infectivity likely due to the structural changes in the viral membrane caused 
by the incorporation of the unsaturated fatty acids; however, reduced infectivity was not 
observed for viruses incubated with saturated fatty acids. As viral membranes typically 
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contain more saturated fatty acids in comparison to unsaturated fatty acids and are therefore 
more “rigid,” the incorporation of unsaturated fatty acids into the viral envelope disrupts its 
ability to replicate via budding.8  
In regards to obesity, this condition yields a myriad of physiological symptoms that 
are detrimental to an individual’s health. It is associated with high blood pressure, Type 2 
Diabetes, heart disease, non-alcoholic fatty liver disease, metabolic syndrome, and more.12 
One consequence of obesity with a possible role in influenza infection is elevated serum fatty 
acid levels. Increased serum levels are likely a consequence of a greater release of free fatty 
acids in obese individuals compared to lean individuals due to larger adipose stores in the 
obese.3 The elevation in plasma levels primarily reflects an increase in the serum levels of 
saturated fatty acids rather than all types of fatty acids.21 From a population-based cohort 
study of 4,232 subjects, it was determined that elevated serum palmitate (16:0) levels 
correlate with abdominal obesity and a higher BMI, whereas serum linoleic acid (18:2) and 
alpha-linoleic acid (18:3) levels are inversely related to abdominal obesity and BMI.1 With 
this in mind, it is a question whether composition and levels of serum fatty acid may be 
contributing to obese individuals’ increased risk of influenza infection. 
As abdominally obese individuals typically have elevated amounts of serum saturated 
fatty acids, our research investigates this as a possible mechanism explaining the greater 
incidence of influenza infection in obese individuals.1 In this study, A549 cells were 
incubated with various fatty acids at a low concentration and high concentration. A549 cells 
are cancerous lung epithelial cells widely used in influenza infection studies.9 It has been 
confirmed that A549 cells incorporate serum fatty acids into their membranes with 
incubation.4 By incubating A549 cells with saturated fatty acids, unsaturated fatty acids, or 
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polyunsaturated fatty acids at different concentrations, we may begin to determine if an 
elevation of a particular fatty acid in serum is enhancing obese individuals’ risk for influenza 
infection. Following a 24-hour incubation period, the A549 cells were infected with 
Influenza Virus H1N1 Strain A/PR/8/34. Aliquots of the supernatant were later removed 
from the cells and used to determine the amount of infectious virus produced using the 
TCID50 assay protocol, or the 50% Tissue Culture Infectious Dose. The TCID50 indicates the 
amount of infectious viral titer that is able to produce cytopathic effects in 50% of inoculate 
cells.15 As influenza does not produce cytopathic effects in its host cells, hemagglutination 
was assessed instead. 
With this supporting background information, my hypothesis is that the amount of 
viral titer will be the greatest from A549 cells incubated with the media containing palmitate 
in comparison to that of cells incubated with either oleic acid or linoleic acid. The 
incorporation of the saturated fatty acids into the host cell membrane will not adversely affect 
viral budding and will thus yield the greatest amount of viral reproduction. Cells incubated 
with monounsaturated fatty acids will produce a decreased viral titer, as the incorporation of 
unsaturated fatty acids into the host cell membrane is unfavorable for the more “rigid” viral 
envelope. Because the incorporation of polyunsaturated fatty acids will produce a more fluid 
host cell plasma membrane, the cells incubated with polyunsaturated fatty acids will produce 
the least amount of viral titer due to the disruption of viral budding.  
Materials and Methods 
Cell Lines 
A549 and MDCK cells were grown separately and regularly split. Both cell lines 
were grown in Dulbecco’s Modified Eagle Medium containing 0.025mM D-glucose, L-
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glutamine, and 1mM sodium pyruvate with additional 10% fetal calf serum, L-glutamine, 
and penicillin/streptomycin.  
Fatty Acid Preparations 
Solutions of 5mM palmitate (16:0), oleic acid (18:1), linoleic acid (18:2), and a 
control of 1:1 ethanol to water were prepared. First, 60 mg of solid bovine serum albumin 
was combined into 5 mL of water to make 1% fatty acid free bovine serum albumin. The 
solution was stirred for 30 minutes, and additional water was added to reach 6 mL of 1% FA 
free BSA.  
To prepare the control vehicle, 965 !" 1% FA free BSA with 10 !" butylated 
hydroxytoulene, 12.5 !" of ethanol, and 12.5 !" of water. To prepare the palmitic acid 
solution, 965 !" 1% FA free BSA was combined with 10 !" BHT and 25 !" of 200 mM 
palmitic acid. The oleic acid and linoleic acid solutions were prepared similarly to the 
palmitic acid solution, using oleic acid and linoleic acid respectively in place of palmitic 
acid. BHT functions as an antioxidant in the solution to minimize fatty acid oxidation. 
The fatty acid solutions and control were placed in an incubator shaker at 37°C for 45 
minutes to allow the fatty acids to conjugate to albumin. All solutions were then sterile 
filtered. The final 5mM solutions and the control solution were kept frozen at -20°C. 
Fatty Acid Incorporation and Viral Infection 
A549 cells were split into 24-well plates, using 0.20 mL of cells and 1.25 mL of 
DMEM media. The plates were incubated overnight at 37°C. From each 5 mM fatty acid 
solution, two dilutions of 50 !" and 200 !" were made using DMEM without FBS. Each 
plate of cells was inoculated with 1 mL of either concentration of palmitic acid, oleic acid, or 
linoleic acid. As viability controls, one row of cells on each plate was incubated with the 
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control vehicle, and another row of cells on each plate was solely incubated with DMEM no 
FBS. The plates were then incubated for 24 hours at 37°C. 
Following the 24-hour incubation period, cells were inoculated with 128 HAU of 
Influenza Virus H1N1 Strain A/PR/8/34. The plates were then incubated at 37°C for one 
hour. Next, 1 mL of the corresponding fatty acid concentration media was added back to the 
cells. The plates were placed in the incubator at 37°C again for an hour. An aliquot of 100 !" 
was removed from each well, and the plates were placed back in the incubator. Aliquots of 
100 !" were taken from the supernatant at the hour mark for 6 hours, then at 24 hours and 48 
hours from addition of virus. Virus aliquots were stored in -80°C. 
Influenza Virus TCID5015 
The following Influenza Virus TCID50 procedure was repeated for each hour aliquot 
of each fatty acid condition. 
First, trypsin with EDTA was added to a confluent 75 cm2 flask of Madin-Darby 
Canine Kidney cells, and the cells were re-suspended in 40 mL of DMEM per flask. Then, 
100 !" of cells was dispensed into each well of the 96-well round-bottom plates. The cells 
were incubated overnight at 37°C. 
Serum-free DMEM with trypsin was prepared by adding 0.8 mL of 0.25% trypsin 
without EDTA per 100 mL DMEM. Then, 180 !" of the trypsin-containing media was added 
to each well of sterile, round-bottom 96-well plates. To prepare the virus dilutions, 20 !" of 
the viral aliquot was added to the first well in each column. Using a multichannel pipet, the 
first row of wells containing the virus suspension was mixed, and 20 !" was transferred from 
row 1 to row 2. This process was completed down to the 6th row, changing tips between each 
row. 
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The media was removed from the plate containing the MDCK cells. Using a 
multichannel pipette, 100 !" of the virus dilution was transferred to the corresponding well 
containing MDCK cells. The plate was incubated for 5 days at 37°C. 
 A hemagglutination assay was used to determine the tissue culture infectious dose 
that will infect 50% of inoculated cells (TCID50). A 0.5% turkey red blood cell suspension 
was prepared, and 50 !" of the solution was dispensed into each well of the plate. The plate 
was left to settle for 2 hours, after which hemagglutination was assessed to determine the 
TCID50. 
The TCID50 is a measure of the amount of infectious viral titer produced. It indicates 
the amount of virus necessary to produce cytopathic effects in 50% of the cells that are 
inoculated with the virus. As the influenza virus does not produce cytopathic effects on the 
host cell, a modified version of the TCID50 assay protocol was used. Hemagglutination was 
assessed as the equivalent of cytopathic effects in the host cell. Hemagglutination occurs if 
the viral hemagglutinin protein is able to bind the turkey red blood cells in sufficient amounts 
to create a “mat”. If hemagglutination does not occur, the turkey red blood cells settle as a 
single red button in the well. The presence of hemagglutination is determined to be positive, 
and the presence of a red blood cell button is determined to be negative. The following 
equation was used to determine the TCID50 of each plate using the results from the 
hemagglutination assay.  
 
!"#$%&!!"!"" !" = dilution where > 50% have CPE+ % !"#$%$&' !"#$% !"% !!"%%"#$%&%'( !"#$% !"% ! %"!"#$#%& !"#$% !"%   
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Results 
  The results of the TCID50 were assessed in various manners to determine if there was 
a significant relationship between the amount of infectious viral titer produced and the type 
of fatty acid in the media or the concentration of the fatty acids in the media. Using the 
statistical software PRISM, an outlier was identified and removed from the data. The outlier 
was a TCID50 value of 4.22×10! TCID50 at 2 hours following initial infection in the control 
group. 
Separating the results by the type of fatty acid used in the media for in the 24-hour 
incubation period yielded the graphs shown in Figure 1. A 2-way ANOVA comparing 
TCID50 values of the cells grown in the 50 !" SFA media, 200 !" SFA media, and the 
control yielded no significant difference between any conditions at any time. This was also 
true for the TCID50 values of the cells grown in the monounsaturated fatty acid medias. A 2-
way ANOVA comparing the TCID50 values of the conditions for the cells grown in the 
polyunsaturated fatty acid medias indicated that after 2 hours of initial infection the TCID50 
of the cells grown in 50 !" PUFA media, 1.47×10! TCID50, was significantly greater than 
the TCID50 of the cells grown in 200 !" PUFA media, 2.37×10! TCID50 (p-value = 0.0271; 
95 CI 10252, 236348). With the cells grown in the PUFA containing media there is a general 
trend that at every hour the cells grown in the 50 !" PUFA media have the greatest TCID50, 
followed by those grown in the 200 !" PUFA solution, and the control cells yield the lowest 
amount of infectious virus produced.	 
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 The TCID50 values were also separated and analyzed based on concentration of fatty 
acid in the media, as shown in Figure 2. A 2-way ANOVA of TCID50 values from cells 
grown in 200 !" fatty acid medias indicate no difference between the TCID50 values of cells 
grown in any fatty acid media at any hour. A 2-way ANOVA of TCID50 values from cells 
grown in 50 !" fatty acid medias indicates that at 2 hours following initial infection, the 
TCID50 value of the cells grown in PUFA media, 1.47×10! TCID50, was significantly 
greater than the TCID50 of the cells grown in MUFA media, 1.38×10! TCID50 (p-
value=0.0022; 95 CI -220668, -45732), and the TCID50 of the cells grown in SFA media, 
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Figure 1. The logTCID50 values separated on the basis on the fatty acid in the media. 
Though there was no significance between the viral titers in the measures from cells 
incubated in saturated fatty acid or monounsaturated fatty acid, the viral titer from cells 
incubating in 50 !" PUFA was significantly greater than the titer measured from cells 
incubating in 200 !" PUFA. An outlier value of 4.22×10! TCID50 at 2 hours in the 
control group was removed. 	
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1.33×10! TCID50 (p-value=0.0021; 95 CI 46232, 221168). In addition, at 5 hours following 
initial infection, the TCID50 of the cells grown in PUFA media, 7.20×10! TCID50, is 
significantly greater than the TCID50 of the cells grown in MUFA media, 2.78×10! TCID50 
(p-value= 0.0265, 95 CI -184618, -9682), and it is also significantly greater than the TCID50 
of the cells grown in the control media, 4.64×10! TCID50 (p-value= 0.0425, 95 CI 2532, 
177468). 
  
Figure 2. The logTCID50 values separted on the basis of concentration of the fatty acid 
media. At 2 hours post-infection in 50 uM media, the cells in PUFA containing media had a 
signifincantly higher viral titer than those in the MUFA and SFA containing media. At 5 
hours post-infection in 50 uM media, the cells in PUFA containing media also had a 
significantly higher viral titer than those in the MUFA containing media and control group. 
There was no signifncance between the viral titers measured from cells incubating in any 
fatty acid media at 200 uM. An outlier value of 4.22×10! TCID50 at 2 hours in the control 
group was removed. 
 	 A one-way ANOVA was performed to examine differences between the mean 
TCID50 values of the various conditions and the control, as shown in Figure 3. The mean 
TCID50 from the cells grown in the 50 !" PUFA media, 7.4986×10! TCID50 was 
significantly greater than the TCID50 from the cells grown in the control media, 7.128×10! 
TCID50 (p-value<0.0001; 95 CI -102165, -33550), the TCID50 from cells grown in the 50 !" 
MUFA media, 4.451×10! TCID50 (p-value<0.0001; 95 CI -104102, -36966), and the 
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TCID50 from the cells grown in the 50 !" SFA media, 6.679×10! TCID50 (p-value= 
0.0006; 95 CI 17223, 84360). The mean TCID50 from the cells grown in 50 !" PUFA were 
also signifincalty greater than the mean TCID50 from the cells grown in 200 !" MUFA, 2.8553×10! TCID50 (p-value= 0.0019; 95 CI 12864, 80001), the mean TCID50 from the 
cells grown in 200 !" PUFA, 2.7206×10! TCID50 (p-value= 0.0013, 95 CI 14212, 81348), 
and the mean TCID50 from the cells grown in 200 !" SFA, 6.679×10! TCID50 (p-
value<0.0001; 95 CI 34739, 101875). 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. TCID50 values at each time point following initial infection (2 hr, 3 hr, 4 hr, 5 hr, 6 
hr, 24 hr, 48 hr) for cells incubating in each fatty acid media condition and the vehicle 
control. An outlier value of 4.22×10! TCID50 in the control group was removed. The mean 
TCID50 value was statistically greater than the mean TCID50 values of the other conditions. 
 
Change of the TCID50 values from each time point of each fatty acid media condition 
in comparison to the TCID50 values of the cells grown in the control media was assessed by 
determining fold-change, as shown in tables 1-6. The TCID50 of the cells grown in 50 !" 
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MUFA were consistently lower than that of the control cells, as shown in table 3. The cells 
grown in the 50 !" PUFA and the 200 !" PUFA consistently yielded a higher TCID50 than 
the control cells at every time point, as shown in tables 5 and 6. In regards to the other 
conditions, there was no consistent trend in the fold-change between the TCID50 of the 
variables and the TCID50 of the control cells. The average fold-changes between the TCID50 
of control cells and TCID50 values from cells in 50 !" SFA, 200 !" MUFA, 50 !" PUFA, 
and 200 !" PUFA were positive. The average fold-changes between the TCID50 of control 
cells and TCID50 values from cells in 200 !" SFA and 50 !" MUFA were negative and 
indicative of lower average TCID50 values. 
 
Time (hours post-
infection) 
TCID50 of Cells in 
Control 
TCID50 of Cells in 50 
uM Saturated FA 
Fold-Change 
2 n/a 1.33×10! TCID50  n/a 
3 5.62×10! TCID50 6.81×10! TCID50  11.12 
4 1.00×10! TCID50 4.08×10! TCID50 3.08 
5 1.00×10! TCID50 2.61×10! TCID50 1.61 
6 4.64×10! TCID50 1.21×10! TCID50 1.61 
24 1.00×10! TCID50 3.98×10! TCID50 -0.70 
48 2.51×10! TCID50 4.98×10! TCID50 0.98 
AVERAGE TCID50 1.214×10! TCID50 2.419×10! TCID50 0.99 
Table 1. Fold-change of TCID50 values from cells in 50 !" SFA compared to TCID50 values 
of control cells. An outlier at 2 hours post-infection from the control group was removed 
from the data. 
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Time (hours post-
infection) 
TCID50 of Cells in 
Control 
TCID50 of Cells in 
200 uM Saturated FA 
Fold-Change 
2 n/a 5.62×10! TCID50 n/a 
3 5.62×10! TCID50 6.81×10! TCID50 0.21 
4 1.00×10! TCID50 6.81×10! TCID50 -0.32 
5 1.00×10! TCID50 4.22×10! TCID50 -0.58 
6 4.64×10! TCID50 1.47×10! TCID50 2.17 
24 1.00×10! TCID50 6.81×10! TCID50 -0.32 
48 2.51×10! TCID50 1.78×10! TCID50 -0.29 
AVERAGE TCID50 1.214×10! TCID50 6.679×10! TCID50 -0.45 
Table 2. Fold-change of TCID50 values from cells in 200 !" SFA compared to TCID50 
values of control cells. An outlier at 2 hours post-infection from the control group was 
removed from the data. 
 
Time (hours post-
infection) 
TCID50 of Cells in 
Control 
TCID50 of Cells in 50 uM 
Monounsaturated FA 
Fold-Change 
2 n/a 1.38×10! TCID50 n/a 
3 5.62×10! TCID50 5.13×10! TCID50 -0.09 
4 1.00×10! TCID50 3.51×10! TCID50 -0.65 
5 1.00×10! TCID50 2.85×10! TCID50 -0.71 
6 4.64×10! TCID50 2.78×10! TCID50 -0.40 
24 1.00×10! TCID50 2.37×10! TCID50 -0.76 
48 2.51×10! TCID50 7.20×2 TCID50 -0.71 
AVERAGE TCID50 1.214×10! TCID50 3.116×10! TCID50 -0.63 
Table 3. Fold-change of TCID50 values from cells in 50 !" MUFA compared to TCID50 
values of control cells. An outlier at 2 hours post-infection from the control group was 
removed from the data. 
 
Time (hours post-
infection) 
TCID50 of Cells in 
Control 
TCID50 of Cells in 200 
uM Monounsaturated FA 
Fold-Change 
2 n/a 3.16×10! TCID50 n/a 
3 5.62×10! TCID50 3.55×10! TCID50 5.32 
4 1.00×10! TCID50 5.18×10! TCID50 4.18 
5 1.00×10! TCID50 5.18×10! TCID50 4.18 
6 4.64×10! TCID50 2.51×10! TCID50 4.41 
24 1.00×10! TCID50 3.51×10! TCID50 -0.65 
48 2.51×10! TCID50 5.62×10! TCID50 -0.78 
AVERAGE TCID50 1.214×10! TCID50 2.855×10! TCID50 1.35 
Table 4. Fold-change of TCID50 values from cells in 200 !" MUFA compared to TCID50 
values of control cells. An outlier at 2 hours post-infection from the control group was 
removed from the data. 
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Time (hours post-
infection) 
TCID50 of Cells in 
Control 
TCID50 of Cells in 50 uM 
Polyunsaturated FA 
Fold-Change 
2 n/a 1.47×10! TCID50 n/a 
3 5.62×10! TCID50 5.62×10! TCID50 9 
4 1.00×10! TCID50 7.20×10! TCID50 6.2 
5 1.00×10! TCID50 1.00×10! TCID50 9 
6 4.64×10! TCID50 7.20×10! TCID50 14.51 
24 1.00×10! TCID50 5.62×10! TCID50 4.62 
48 2.51×10! TCID50 2.15×10! TCID50 7.57 
AVERAGE TCID50 1.214×10! TCID50 7.499×10! TCID50 5.18 
Table 5. Fold-change of TCID50 values from cells in 50 !" PUFA compared to TCID50 
values of control cells. An outlier at 2 hours post-infection from the control group was 
removed from the data. 
 
Time (hours post-
infection) 
TCID50 of Cells in 
Control 
TCID50 of Cells in 200 
uM Polyunsaturated FA 
Fold-Change 
2 n/a 2.37×10! TCID50 n/a 
3 5.62×10! TCID50 3.51×10! TCID50 5.25 
4 1.00×10! TCID50 2.78×10! TCID50 1.78 
5 1.00×10! TCID50 2.78×10! TCID50 1.78 
6 4.64×10! TCID50 3.16×10! TCID50 5.81 
24 1.00×10! TCID50 3.98×10! TCID50 2.98 
48 2.51×10! TCID50 4.64×10! TCID50 0.85 
AVERAGE TCID50 1.214×10! TCID50 2.721×10! TCID50 1.24 
Table 6. Fold-change of TCID50 values from cells in 200 !" PUFA compared to TCID50 
values of control cells. An outlier at 2 hours post-infection from the control group was 
removed from the data. 
 
Discussion 
 Contrary to the hypothesis stated, the viral titer from the cells incubated with 
palmitate was not the highest. Though hypothesized that the TCID50 from the cells incubated 
with the polyunsaturated fatty acid containing medias would be among the lowest, the cells 
incubated in the 50 !" PUFA media actually produced the greatest average viral titer of all 
conditions. Incubation of the A549 cells in 50 !" PUFA media, 200 !" MUFA media, 200 !" PUFA media, and 50 !" SFA media all produced an average TCID50 greater than that of 
the control, though only the average TCID50 of the cells incubated with 50 !" PUFA was 
considered to be significantly greater. On the other hand, incubation of the host cell in the 
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200 !" SFA media and 50 !" MUFA media yielded average TCID50 values that were less 
than that of the control cells, though neither comparison was significant. In addition, there 
did not appear to be a clear, consistent trend regarding amount of infectious virus produced 
and the concentration of fatty acid medias. In general, incubation with a PUFA containing 
media increased the viral titer whereas incubation with a SFA or MUFA containing media 
yielded mixed results. The findings from this project appear to align with a previous study by 
Beck et al. who found that fish oil fed mice had a higher viral load in the lungs following 
influenza infection in comparison to the control mice. This study implicated the anti-
inflammatory properties of fish oil feeding as cause for fewer CD8+ T cells and decreased 
expression of various inflammatory signaling proteins such as TNF-a and IL-6.19 As the cell 
culture in this project only contained A549 cells and did not contain immune cells, it may be 
possible that inflammatory cytokines produced by the host cell are having an effect on viral 
infectivity. 
 It is important to consider that the study done by Kohn et al. incubated the influenza 
virus directly in the fatty acid solutions, whereas the host cells were incubated with the fatty 
acids in this project with the goal of changing the host cell membrane from which viral 
particles bud off.8 The substrate of incubation may have had an effect based on the difference 
between directly incorporating the fatty acids into the viral envelope versus incorporation of 
the fatty acids into the host cell membrane. The incorporation of fatty acids into host cells 
may affect other aspects of the cell beyond viral budding, such as cell signaling and 
production of cytokines, whereas incorporation into the lipid bilayer of the virus would not 
induce such effects.14 Though there is literature regarding the effects of omega-3 fatty acids 
on cell signaling and defense, there seems to be a gap in the literature regarding omega-6 
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fatty acids, such as linoleic acid, and their role. It is important to consider the possibility for 
different effects with omega-3 and omega-6 fatty acids, as omega-3 FA are touted to be anti-
inflammatory and omega-6 FA are seen as pro-inflammatory.20 
Limitations in this project include the representation of serum fatty acids used in the 
incubation process. In reality, human serum contains a variety of fatty acids and is not 
limited to a single type. It is possible that the results would differ if various fatty acids were 
used in the media rather than merely exposing the host cell to one type. In addition, the 
concentrations of fatty acids used in this project corresponded with the findings of a previous 
Belgian study characterizing nonesterified fatty acid levels. For palmitate, oleic acid, and 
linoleic acid, the 50 !" value is within the range of average observed concentrations, and 
200 !" was arbitrarily chosen to be the high concentration.16 These values may not 
accurately reflect the fatty acid levels in obese American individuals and thus, different 
concentrations of fatty acids may have a more accurate representation of normal serum levels 
and elevated serum levels. In addition, it has been shown that different fatty acids are 
cytotoxic at different concentration ranges, depending on the cell type.2 It is possible that the 
fatty acids used may have different cytotoxic levels on A549 cells, which may have affected 
cell growth and subsequent viral production. Further limitations include plate-to-plate 
variability. As each type of fatty acid was treated on a separate 24-well plate and each 
supernatant assayed on a separate 96-well plate, it is possible that there were subtle variations 
between the plates that may have contributed to or masked significant differences. 
 The results of my study provide some direction for future areas of research regarding 
obesity, lipids and influenza. With future research of similar design, the amount and identity 
of fatty acids incorporated into the membranes of A549 cells should be determined as a 
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means of investigating the cell’s propensity to incorporate a type of fatty acid and to ensure 
that incorporation is occurring. Fatty acids used in media should also more accurately reflect 
the variety in human serum, both in obese and non-obese individuals. In addition, cytotoxic 
concentrations of fatty acids should be determined for the cell line in use. Other areas for 
future research include the differences of omega-3 and omega-6 FA in regards to cell defense 
and influenza infection. As mentioned previously, omega- 3 FA are known to be anti-
inflammatory while omega-6 FA are pro-inflammatory.20 With increased investigation into 
the effects of omega-3 FA on cell cytokine production and defense, it may be interesting to 
determine differences of infection with omega-6 FA.   
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